ClearPoint Neuro (CLPT) Current Deferred Revenue (2011 - 2026)
ClearPoint Neuro recorded quarterly Current Deferred Revenue of $1.8 million in Q1 2026, down 19.38% quarter-over-quarter from $2.2 million in Q4 2025, and down 8.15% year-over-year from $2.0 million in Q1 2025.
ClearPoint Neuro's Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 8.15% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 8.15% YoY), while the FY2025 annual figure was $2.2 million, up 6.08% from the prior year.
- Current Deferred Revenue came in at $1.8 million for Q1 2026 at ClearPoint Neuro, down from $2.2 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $3.2 million in Q4 2023 to a low of $541000.0 in Q1 2022.
- A 5-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 136.78% in 2023 and tumbled 32.75% in 2024, its largest moves.
- ClearPoint Neuro's Current Deferred Revenue stood at $1.5 million in 2022, then soared by 116.47% to $3.2 million in 2023, then sank by 32.75% to $2.1 million in 2024, then increased by 6.08% to $2.2 million in 2025, then dropped by 19.38% to $1.8 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.8 million, $2.2 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 724,000.00 |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 735,000.00 |
| Jun 30, 2022 | 675,000.00 |
| Mar 31, 2022 | 541,000.00 |
| Dec 31, 2021 | 678,000.00 |
| Sep 30, 2021 | 440,000.00 |
| Jun 30, 2021 | 368,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2020 | 562,000.00 |
| Sep 30, 2020 | 767,969.00 |
| Jun 30, 2020 | 620,126.00 |
| Mar 31, 2020 | 857,813.00 |
| Dec 31, 2019 | 1.02 Mn |
| Sep 30, 2019 | 1.10 Mn |
| Jun 30, 2019 | 740,163.00 |
| Mar 31, 2019 | 679,485.00 |
| Dec 31, 2018 | 210,768.00 |
| Sep 30, 2018 | 421,432.00 |
| Jun 30, 2018 | 214,701.00 |
| Mar 31, 2018 | 216,632.00 |
| Dec 31, 2017 | 256,178.00 |
| Dec 31, 2016 | 223,117.00 |
| Sep 30, 2016 | 222,488.00 |
| Jun 30, 2016 | 222,637.00 |
| Mar 31, 2016 | 151,706.00 |
| Dec 31, 2015 | 116,009.00 |
| Sep 30, 2015 | 165,562.00 |
| Jun 30, 2015 | 73,220.00 |
| Mar 31, 2015 | 97,840.00 |
| Dec 31, 2014 | 102,710.00 |
| Sep 30, 2014 | 94,063.00 |
| Jun 30, 2014 | 34,040.00 |
| Mar 31, 2014 | 125,367.00 |
| Dec 31, 2013 | 106,859.00 |
| Sep 30, 2013 | 110,265.00 |
| Jun 30, 2013 | 75,787.00 |
| Dec 31, 2012 | 112,725.00 |
| Sep 30, 2012 | 2.05 Mn |
| Jun 30, 2012 | 2.70 Mn |
| Mar 31, 2012 | 3.35 Mn |
| Dec 31, 2011 | 2.60 Mn |